Joshua Noe
Appearances
- DateMay 20, 2024BACKGROUND: Given the variable response to anti-TNF therapy in patients with Crohn’s disease (CD), we hypothesized there is a core biologic (inflammatory) signature associated with early response and endoscopic healing (EH)…
Presenter
Speakers
Cincinnati Children’s Hospital Medical Center - DateMay 21, 2024BACKGROUND: Prior pharmacokinetic (PK) investigations have identified an association between anti-TNF trough concentrations (cTrough) and clinical or biochemical remission for children with Crohn’s Disease (CD)…
Presenter
Speakers
Cincinnati Children’s Hospital Medical Center